Peroxisomal beta-oxidation and steatohepatitis

Area of Science:

• Metabolic biochemistry
• Molecular biology
• Hepatology

Background:

• Fatty acid beta-oxidation occurs in mitochondria and peroxisomes, generating energy and H2O2.
• Peroxisomes metabolize very long-chain fatty acids (VLCFAs) and dicarboxylic acids (DCAs) produced by CYP4A omega-oxidation.
• Peroxisome proliferator-activated receptor alpha (PPAR alpha) regulates genes for fatty acid metabolism.

Purpose of the Study:

• Investigate the role of PPAR alpha-inducible oxidation systems in hepatic steatosis.
• Understand the molecular mechanisms of nonalcoholic microvesicular hepatic steatosis and steatohepatitis.
• Elucidate the impact of fatty acid oxidation defects on energy-related stress responses.

Main Methods:

• Utilized mouse models deficient in PPAR alpha (PPAR alpha-/-), fatty acyl-CoA oxidase (AOX-/-), and both (PPAR alpha-/-AOX-/-).
• Analyzed the pathogenesis of nonalcoholic microvesicular hepatic steatosis and steatohepatitis in these models.
• Examined the steatotic response to fasting in relation to PPAR alpha-inducible fatty acid oxidation.

Main Results:

• Mice deficient in AOX develop severe microvesicular steatosis and steatohepatitis due to disrupted oxidation of VLCFAs and DCAs.
• Loss of AOX leads to sustained PPAR alpha hyperactivation, indicating unmetabolized substrates act as PPAR alpha ligands.
• PPAR alpha-deficient and PPAR alpha/AOX-double-deficient mice show exaggerated steatosis during fasting, highlighting the role of PPAR alpha-inducible oxidation in energy stress.

Conclusions:

• PPAR alpha-inducible peroxisomal and microsomal oxidation systems are critical for preventing hepatic steatosis.
• Defects in these oxidation pathways exacerbate fatty liver disease under fasting conditions.
• Mouse models provide insights into the molecular mechanisms of hepatic steatosis and steatohepatitis.